By analyzing data from 9 laboratories, researchers assessed whether the monocyte activation test could consistently and accurately measure the pyrogenic content of the first meningococcal B vaccine to be...
When PCV7 was introduced in pediatric immunization programs, adults experienced a significant decrease in pneumococcal disease. A new study evaluated the more recent introduction of the PCV13 and its impact...
While it is known that disease progression of HIV-1 is delayed by HIV-2 in coinfected individuals, authors of a new study sought to identify the protective mechanisms of the coinfection.
While it is known that disease progression of HIV-1 is delayed by HIV-2 in coinfected individuals, authors of a new study sought to identify the protective mechanisms of the coinfection.
In an effort to support the recommendation that pregnant women receive the seasonal influenza vaccination, the authors of a new study sought to determine the effects of influenza on risk of hospitalization...
Each year, influenza viruses cause up to 650,000 deaths. To aid in the development of a universal influenza virus vaccine that would save more lives, authors of a new study sought to identify alternative...
The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...
After 2 randomized clinical trials found it as safe and effective as the standard 3-drug regimen, the FDA approved the first 2-drug regimen for adults with HIV-1 who have never been treated with ART.
